In exchange, 3SBio will receive $1.25bn upfront from Pfizer and will be eligible for certain development, regulatory and ...

VML France has announced the appointment of Philippe Huot-Louradour as director of VML Health France. Hout, who has also been ...

Merck & Co – known as MSD outside of the US and Canada – has announced that its Welireg (belzutifan) has been approved by the ...

Medscape Education is proud to announce the presentation of eight innovative educational research publications at the ...

MSD – known as Merck & Co in the US and Canada – has received approval from the Medicines and Healthcare products Regulatory ...

In an era where clinician time is stretched thin, AI and digital innovation are transforming continuing medical education ...

AbbVie and ADARx Pharmaceuticals have announced a multi-billion dollar partnership to develop small interfering RNA (siRNA) ...

Understanding why people join clinical trials is essential to improving recruitment and designing better research. Explores ...

The US Food and Drug Administration (FDA) has approved Fujirebio Diagnostics’ Alzheimer’s disease (AD) blood test to help ...

Johnson & Johnson (J&J) has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) for its ...

Sanofi has unveiled plans to invest “at least” $20bn into the US by 2030, with the commitment including a significant ...

The US regulator’s decision was supported by results from the phase 3 HELIOS-B trial, in which Alnylam’s drug reduced the risk of all-cause mortality (ACM) and recurrent cardiovascular events by 28% ...